Literature DB >> 15451473

A new CD21low B cell population in the peripheral blood of patients with SLE.

Claudia Wehr1, Hermann Eibel, Madhan Masilamani, Harald Illges, Michael Schlesier, Hans-Hartmut Peter, Klaus Warnatz.   

Abstract

A hallmark of systemic lupus erythematosus (SLE) is the production of autoantibodies. Recent reports suggest an abnormal peripheral blood B cell homeostasis in SLE patients without being conclusive. We analyzed by four color flow-cytometry peripheral blood B cell subpopulations of SLE patients, healthy donors, and patients with other systemic autoimmune diseases. IgM memory but not switched memory B cells of SLE patients were significantly decreased compared to healthy donors, whereas transitional B cells, characterized by CD19+IgMhiIgD+CD24hiCD38hi, were significantly expanded in SLE patients but also found in other autoimmune disorders. The population of plasmablasts (CD19loCD21loCD27++CD38++) was increased in active disease. Most interestingly, B cells in autoimmune disorders contain a so far uncharacterized subpopulation with an activated phenotype (CD19hiCD21loCD38loCD86int). None of the identified subpopulations was associated with current or previous therapy and therefore may represent different aspects of the disturbed B cell homeostasis in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451473     DOI: 10.1016/j.clim.2004.05.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  119 in total

1.  Reference values for B cell subpopulations from infancy to adulthood.

Authors:  H Morbach; E M Eichhorn; J G Liese; H J Girschick
Journal:  Clin Exp Immunol       Date:  2010-09-20       Impact factor: 4.330

2.  A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  K Szabó; G Papp; A Szántó; T Tarr; M Zeher
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

Review 3.  Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model.

Authors:  Zhiwei Xu; Laurence Morel
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

4.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

5.  Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis.

Authors:  Hiroyoshi Doi; Shiroh Tanoue; David E Kaplan
Journal:  Clin Immunol       Date:  2013-12-17       Impact factor: 3.969

6.  Molecular and phenotypic abnormalities of B lymphocytes in patients with Wiskott-Aldrich syndrome.

Authors:  Karen L Simon; Stacie M Anderson; Elizabeth K Garabedian; Daniele Moratto; Robert A Sokolic; Fabio Candotti
Journal:  J Allergy Clin Immunol       Date:  2013-11-08       Impact factor: 10.793

7.  Expanding mechanistic insights into the pathogenesis of idiopathic CD4+ T cell lymphocytopenia.

Authors:  Jose S Campos; Sarah E Henrickson; Roshini S Abraham
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

8.  Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells.

Authors:  Jie Zhang; Annett M Jacobi; Tao Wang; Betty Diamond
Journal:  Mol Med       Date:  2008-07-30       Impact factor: 6.354

Review 9.  B cells in autoimmunity.

Authors:  Thomas Dörner; Annett M Jacobi; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

10.  Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor.

Authors:  M Margarida Souto-Carneiro; Vijayabhanu Mahadevan; Kazuki Takada; Ruth Fritsch-Stork; Toshihiro Nanki; Margaret Brown; Thomas A Fleisher; Mildred Wilson; Raphaela Goldbach-Mansky; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2009-06-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.